Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Premade Virus Particles
Ready-to-Use | High Titer | Versatile Applications
Premade AAV, adenovirus, lentivirus particles, safe, stable, in stock.
Virus-Like Particles (VLPs)
Stable | Scalable | Customizable
Advanced VLPs for vaccine development (Chikungunya, Dengue, SARS-CoV-2), gene therapy (AAV1 & AAV9), and drug screening (SSTR2, CCR5).
Oligonucleotide Products
Precise | High Yield | Tailored Solutions
Accelerate your research with cost-effective LncRNA qPCR Array Technology.
RNA Interference Products
Targeted | Potent | High Specificity
Human Druggable Genome siRNA Library enables efficient drug target screening.
Recombinant Drug Target Proteins
Authentic | Versatile | Accelerated
Providing functional, high-purity recombinant proteins—including membrane proteins and nanodiscs—to overcome bottlenecks in drug screening and target validation.
Clones
Validated | Reliable | Comprehensive Collection
Ready-to-use clones for streamlined research and development.
Kits
Complete | Convenient | High Sensitivity
Chromogenic LAL Endotoxin Assay Kit ensures precise, FDA-compliant endotoxin quantification for biosafety testing.
Enzymes
Purified | Stable | Efficient
Powerful Tn5 Transposase for DNA insertion and random library construction.
Aptamers
Highly Specific | Robust | Versatile
Aptamers for key proteins like ACVR1A, Akt, EGFR, and VEGFR.
Adjuvants
Enhancing | Synergistic | Effective
Enhance immune responses with high-purity, potent CpG ODNs.
Laboratory Equipment
Innovative | Reliable | High-Precision
Effortlessly streamline DNA extraction with CB™ Magnetic-Nanoparticle Systems.
Stable Cell Line Generation
Reliable | Scalable | Customizable
Fast proposals, regular updates, and detailed reports; strict quality control, and contamination-free cells; knockout results in 4-6 weeks.
Target-based Drug Discovery Service
Innovative | Comprehensive | Efficient
Target identification, validation, and screening for drug discovery and therapeutic development.
Custom Viral Service
Versatile | High-Yield | Safe
Unbeatable pricing, fully customizable viral packaging services (covering 30,000+ human genes, 200+ mammals, 50+ protein tags).
Custom Antibody Service
Precise | Flexible | Efficient
End-to-end antibody development support, from target to validation, enabling clients to rapidly obtain application-ready antibodies.
Antibody-Drug Conjugation Service
Integrated | Controlled | Translational
Comprehensive solutions covering design, development, and validation to ensure conjugated drugs with consistent quality and clinical potential.
Protein Degrader Service
Efficient | High-Precision | Advanced Therapeutics
Harness the power of protein degraders for precise protein degradation, expanding druggable targets and enhancing therapeutic effectiveness for cutting-edge drug discovery.
Nucleotides Service
Accurate | Flexible | High-Quality
Custom synthesis of oligonucleotides, primers, and probes for gene editing, PCR, and RNA studies.
Custom RNA Service
Custom RNA ServicePrecise | Flexible | GMP-ReadyCustom
RNA design, synthesis, and manufacturing—covering mRNA, saRNA, circRNA, and RNAi. Fast turnaround, rigorous QC, and seamless transition from research to GMP production.
Custom Libraries Construction Service
Comprehensive | High-throughput | Accurate
Custom cDNA, genomic, and mutagenesis libraries for drug discovery, screening, and functional genomics.
Gene Editing Services
Precise | Efficient | Targeted
Gene editing solutions for gene editing, knockouts, knock-ins, and customized genetic modifications. Integrated multi-platform solutions for one-stop CRISPR sgRNA library synthesis and gene screening services
Microbe Genome Editing Service
Precise | Scalable | Customizable
Enhance microbial productivity with advanced genome editing using Rec-mediated recombination and CRISPR/Cas9 technologies.
Biosafety Testing Service
Reliable | Comprehensive | Regulated
Complete biosafety testing solutions for gene therapy, viral vectors, and biologics development.
Plant Genetic Modification Service
Advanced | Sustainable | Tailored
Genetic modification for crop improvement, biotechnology, and plant-based research solutions.
Plant-based Protein Production Service
Efficient | Scalable | Customizable
Plant-based protein expression systems for biopharmaceuticals, enzyme production, and research.
Aptamers Service
Innovative | Fast | Cost-Effective
Revolutionizing drug delivery and diagnostic development with next-generation high-throughput aptamer selection and synthesis technologies.
CGT Biosafety Testing
Comprehensive | Accurate | Regulatory-compliant
Internationally certified evaluation system for biologics, gene therapies, nucleic acid drugs, and vaccines.
Pandemic Detection Solutions
Rapid | Precise | Scalable
Balancing accuracy, accessibility, affordability, and rapid detection to safeguard public health and strengthen global response to infectious diseases.
cGMP Cell Line Development
Reliable | Scalable | Industry-leading
Stable expression over 15 generations with rapid cell line development in just 3 months.
Supports adherent and suspension cell lines, offering MCB, WCB, and PCB establishment.
GMP mRNA Production
Efficient | Scalable | Precise
Scalable mRNA production from milligrams to grams, with personalized process design for sequence optimization, cap selection, and nucleotide modifications, all in one service.
GMP Plasmid Production
High Quality | Scalable | Regulatory-compliant
Our plasmid production services span Non-GMP, GMP-Like, and GMP-Grade levels, with specialized options for linearized plasmids.
GMP Viral Vector Manufacturing
Scalable | High Yield | Quality-driven
Advanced platforms for AAV, adenovirus, lentivirus, and retrovirus production, with strict adherence to GMP guidelines and robust quality control.
AI-Driven Gene Editing and Therapy
Innovative | Precision | Transformative
AI-powered one-click design for customized CRISPR gene editing strategy development.
AI-Antibody Engineering Fusion
Next-Generation | Targeted | Efficient
AI and ML algorithms accelerate antibody screening and predict new structures, unlocking unprecedented possibilities in antibody engineering.
AI-Driven Enzyme Engineering
Smart | Efficient | Tailored
High-throughput enzyme activity testing with proprietary datasets and deep learning models for standardized and precise enzyme engineering design.
AI-Enhanced Small Molecule Screening
Predictive | Efficient | Insightful
Leverage AI to uncover hidden high-potential small molecules, prioritize leads intelligently, and reduce costly trial-and-error in early drug discovery.
AI-Driven Protein Degrader Drug Development
Innovative | Targeted | Accelerated
Use AI-guided design to optimize protein degraders, addressing design complexity and enhancing efficacy while shortening development timelines.
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
| Cat.No. | Product Name | Price |
|---|
Nucleotide-binding oligomerization domain 2 (NOD2) belongs to the NOD-like receptor family. As an intracellular pattern recognition receptor, NOD2 participates in host cell recognition of pathogens by recognizing the ligand muramyl dipeptide, which mediates immune inflammatory response. Recent studies have found that NOD2 plays an important role in the occurrence and development of various cardiovascular diseases such as myocarditis, atherosclerosis, and myocardial infarction.
NOD2-mediated Signal Transduction
NOD2 also triggers multiple signaling pathways in response to pathogenic microorganisms in the cytoplasm. Studies have shown that respiratory syncytial virus (RSV) infection causes NOD2 to transfer to mitochondria, where it binds to mitochondrial antiviral signaling protein (MAV), activates IRF3 in turn, and then produces IFN-β. Therefore, it is possible that NOD2 binding to peptidoglycan induces the recruitment and activation of RIPK2, and it may also bind to ssRNA, which causes NOD2 to transfer to mitochondria and activate MAV-dependent signaling pathways.
Figure 1. Mechanisms by which muramyl dipeptide (MDP)enters into cells to trigger Nod2 signaling. (Nabhani, Z. A. , et al. 2017)
NOD2 can recognize the lytic product MDP of bacterial cell wall peptidoglycans, and is widely involved in the identification and inflammatory response of intracellular pathogenic microorganisms, but studies have shown that NOD2 can also identify virus components. NOD2 can generate an immune response to single-stranded RNA and can activate IRF3 to produce IFN-β. Infection with respiratory syncytial virus, cytoplasmic stomatitis, or influenza virus can be observed with NOD2-mediated IRF3 activation. Studies have found that NOD2 can recognize human macrophage virus (HCMV) in the herpesviridae family. This virus contains both DNA and RNA. After HCMV infection of U373 glioma cells, the expression of NOD2 increased significantly, downstream inflammatory factors such as IFN-β, IL-8 expression increased, and virus replication was inhibited. However, the same test with herpes virus 1 and herpes virus 2 did not activate NOD2. NOD2 is closely related to mucosal immunity. A large number of studies have shown that the development and development of Crohn's disease, a human intestinal disease, is closely related to the sudden change of NOD2. Studies have found that NOD2 can prevent inflammation of the small intestine by limiting the spread of common Bacteroides.
NOD2 and Disease
Studies have shown that NOD2 functions as a virus pattern recognition receptor-inducing the production of type 1 interferons in the response of the RNA virus, which plays a crucial role. Studies in primary endothelial cells isolated from female reproductive tracts have shown that NOD2 is up-regulated during stimuli such as HIV-1. Therefore, NOD2 may be involved in the regulation of HIV infection. The most common cause of viral myocarditis is coxsackie virus infection. It was found that in cardiac myositis caused by coxsackie virus B3 (CVB3), NOD2 expression increases. Knockout of the mouse NOD2 receptor can improve myocardial inflammation and reduce cardiac function damage. Mesenchymal stem cells (MSC) can improve the symptoms of CVB3-induced myocarditis by inhibiting the expression of NOD2 and reducing the release of inflammatory mediators. These studies suggest that NOD2 plays an important role in viral myocarditis.
The descending aorta was ligated to NOD2 knockout mice and it was found that the worsening of cardiac function was significantly worse than that of wild type mice. In addition, cardiac mass/body mass ratio, cardiac mass/tibia length ratio, and myocardial hypertrophy-related indicators such as myocardial cell cross-sectional area increased significantly, indirectly proving that NOD2 can inhibit myocardial hypertrophy and myocardial fibrosis. Further, the expression of NOD2 and Toll-like receptor 4 (TLR4) in myocardial tissue of wild-type mice increased after ligation of the descending aorta, and the expression of TLR4 in NOD2 gene knockout mice increased even more. Studies have found that after suppressing NOD2 in macrophages with siRNA, macrophages were stimulated with lipopolysaccharide (LPS), a TLR4 receptor agonist, and the inflammatory response in mice was significantly enhanced.
References:
Contact us today for a free consultation with the scientific team and discover how Creative Biogene can be a valuable resource and partner for your organization.
Inquiry
Copyright © Creative Biogene. All rights reserved.